Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
tool compounds
Description:
Chemicals used in biological research to probe or validate the function of specific molecules and pathways.
Related topics:
Computational Drug Discovery Methods (10%),
Receptor Mechanisms and Signaling (7%)
OpenAlex ID:
keywords/tool-compounds
How Ligands Illuminate GPCR Molecular Pharmacology
2017
·
Daniel Wacker
, Raymond C. Stevens
, et al.
·
Cell
·
615
PDF
Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles
2020
·
John K. Eaton
, Laura Furst
, et al.
·
Nature Chemical Biology
·
545
PDF
Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist
2003
·
M.J. Gunthorpe
, H.K. Rami
, et al.
·
Neuropharmacology
·
293
Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors
2016
·
Craig W. Lindsley
, Kyle A. Emmitte
, et al.
·
Chemical Reviews
·
187
Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator
1994
·
K Jalink
, P L Hordijk
, et al.
·
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
·
159
AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965
2018
·
Toby A. Dite
, Christopher G. Langendorf
, et al.
·
Journal of Biological Chemistry
·
141
PDF
Structure-Aided Development of Small-Molecule Inhibitors of ENPP1, the Extracellular Phosphodiesterase of the Immunotransmitter cGAMP
2020
·
Jacqueline A. Carozza
, Jenifer A. Brown
, et al.
·
Cell chemical biology
·
121
PDF
A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets
2012
·
Joost CM Uitdehaag
, Folkert Verkaar
, et al.
·
British Journal of Pharmacology
·
113
PDF
The Discovery and Characterization of ML218: A Novel, Centrally Active T-Type Calcium Channel Inhibitor with Robust Effects in STN Neurons and in a Rodent Model of Parkinson’s Disease
2011
·
Zixiu Xiang
, Analisa D. Thompson
, et al.
·
ACS Chemical Neuroscience
·
113
Identification of pyrimidine derivatives as hSMG-1 inhibitors
2012
·
Ariamala Gopalsamy
, Eric M. Bennett
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
109
Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of ERK1/2
2015
·
Richard A. Ward
, Nicola Colclough
, et al.
·
Journal of Medicinal Chemistry
·
107
Discovery of 1H-Pyrazol-3(2H)-ones as Potent and Selective Inhibitors of Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK)
2015
·
Adrian L. Smith
, Kristin L. Andrews
, et al.
·
Journal of Medicinal Chemistry
·
96
Rotationally Constrained 2,4-Diamino-5,6-disubstituted Pyrimidines: A New Class of Histamine H4Receptor Antagonists with Improved Druglikeness and in Vivo Efficacy in Pain and Inflammation Models
2008
·
Marlon D. Cowart
, Robert J. Altenbach
, et al.
·
Journal of Medicinal Chemistry
·
96
A Cell‐Permeable Ester Derivative of the JmjC Histone Demethylase Inhibitor IOX1
2014
·
Rachel Schiller
, Giuseppe Scozzafava
, et al.
·
ChemMedChem
·
94
PDF
A Profiling Platform for the Characterization of Transglutaminase 2 (TG2) Inhibitors
2010
·
Sabine Schaertl
, Michael Prime
, et al.
·
SLAS DISCOVERY
·
86
PDF
Synthesis and Biological Evaluation of ortho‐Aryl N‐Hydroxycinnamides as Potent Histone Deacetylase (HDAC) 8 Isoform‐Selective Inhibitors
2012
·
Wei‐Jan Huang
, Yi‐Ching Wang
, et al.
·
ChemMedChem
·
85
Key Aspects of the Novartis Compound Collection Enhancement Project for the Compilation of a Comprehensive Chemogenomics Drug Discovery Screening Collection
2005
·
Edgar Jacoby
, Ansgar Schuffenhauer
, et al.
·
Current Topics in Medicinal Chemistry
·
79
Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors
2016
·
Guanglin Luo
, Ling Chen
, et al.
·
Journal of Medicinal Chemistry
·
77
PDF
Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase
2013
·
Reema K. Thalji
, Jeff J. McAtee
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
75
Targeting Nuclear Receptors in Neurodegeneration and Neuroinflammation
2021
·
Sabine Willems
, Daniel Zaienne
, et al.
·
Journal of Medicinal Chemistry
·
68
Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer
2015
·
Hideki Terai
, Li Tan
, et al.
·
ACS Chemical Biology
·
67
PDF
The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophore
2013
·
David G. Washburn
, Dennis A. Holt
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
66
Evidence-Based and Quantitative Prioritization of Tool Compounds in Phenotypic Drug Discovery
2016
·
Yuan Wang
, Allen Cornett
, et al.
·
Cell chemical biology
·
62
PDF
Discovery and SAR of a Series of Agonists at Orphan G Protein-Coupled Receptor 139
2011
·
Feng Shi
, Jing Kang Shen
, et al.
·
ACS Medicinal Chemistry Letters
·
61
NovelN-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1mAChR Agonists
2010
·
Brian Budzik
, Vincenzo Garzya
, et al.
·
ACS Medicinal Chemistry Letters
·
61
Show more works
View as search
Works count:
268
Citation count:
6,408
Year
Topic
Type